VictoryShares US Discovery Enhanced Volatility Wtd ETF CSF 深 滬
已收盤 04-23 16:00:00 美东时间
51.03
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 51.03
- 總市值 2551.50万
- 52周最高 60.2845
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 48.0355
- 委 比 0.00%
- 總股本 50.00万
- 歷史最高 63.1812
- 量 比 0
- 振 幅 0.00%
- 歷史最低 23.3868
- 每 手 1
- 風險率 2.67%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Royal Caribbean Raises FY2025 Adj EPS Guidance from $15.41-$15.55 to $15.58-$15.63 vs $15.67 Est
The company provided the following guidance for the fourth quarter and full year 2025: FUEL STATISTICSFourth Quarter 2025Full Year 2025Fuel Consumption (metric tons)438,0001,712,000Fuel Expenses$286 million$1,140
10-28 18:36
解读ESMO：中国创新药闪耀世界
一年一度的欧洲肿瘤内科学会年会ESMO于10月17日至21日在德国柏林举行，成为中国创新药实力的集中展示舞台，今年ESMO会议上中国创新药的表现格外抢眼...
10-28 13:02
Quest Diagnostics' New Blood Tests Accurately Detect Alzheimer's, Study Finds
Two blood tests, each involving multiple biomarkers, are highly accurate at identifying Alzheimer's disease pathology in symptomatic patients, supporting diagnosis, according to a new study in Neurology®
10-27 19:47
突发！海西新药上市延迟，重启日期成谜
今天，发哥朋友圈被海西新药（02637.HK）上市延迟的消息刷屏了。 海西新药原定于2025年10月17日在港股正式挂牌交易。10月16日晚，公司发布公告称：...
10-17 17:40
Where Syndax Pharmaceuticals Stands With Analysts
Syndax Pharmaceuticals (NASDAQ:SNDX) has been analyzed by 7 analysts in the las...
10-16 22:02
Baird Medical Successfully Performs Minimally Invasive Microwave Ablation On Large Thyroid Nodules At UCSF Health
Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, announced its system was successfully used in two
10-16 20:35
武汉滨会生物冲击IPO，专注于溶瘤病毒领域，机遇与挑战并存
近期，武汉的创新药公司在资本市场大放异彩。 在经过漫长的等待之后，科创板新股武汉禾元生物（688765.SH）终于在10月14日启动申购；与此同时，又有一家来自...
10-14 18:06
Roche, Eli Lilly Alzheimer's blood diagnostic test wins FDA approval
The U.S. FDA has approved Elecsys pTau181, a blood-based biomarker test developed by Roche (OTCQX:RHHBY) and Eli Lilly (NYSE:LLY) that can provide an initial assessment for Alzheimer's disease and cog...
10-14 04:41
天风证券：维持和誉-B“买入”评级 口服PD-L1与多药联用布局
天风证券发布研报称，维持和誉-B（02256）“买入”评级，预计公司2025-2027年的营业收入分别为6.30亿元、6.85亿元和6.37亿元，归母净利润...
10-09 15:17
